Agios to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast on February 12 at 8:00 a.m. ET

Agios (Nasdaq: AGIO) will host a conference call and live webcast on Thursday, February 12, 2026 at 8:00 a.m. ET to report fourth quarter and full year 2025 financial results and business highlights.

Rhea-AI Summary

Agios (Nasdaq: AGIO) will host a conference call and live webcast on Thursday, February 12, 2026 at 8:00 a.m. ET to report fourth quarter and full year 2025 financial results and business highlights. The live webcast will be available on the company’s Investors website under the "Events & Presentations" tab. A replay will be posted on the company website approximately two hours after the event.

Argus Jan 26 session

+1.02% close to close Open Argus

Details

News Market Reaction – AGIO

On Jan 26, the day this news came out, AGIO closed 1.02% above the previous close.

Data tracked by StockTitan Argus for the Jan 26 session.

Market Context

This announcement sets the timing for Agios’s fourth quarter and full year 2025 results, with a webc...

Analysis

This announcement sets the timing for Agios’s fourth quarter and full year 2025 results, with a webcast on February 12, 2026 at 8:00 a.m. ET and a replay available shortly after. Historically, similar conferences/earnings notices produced only modest average moves of about 0.77%, underscoring their routine nature. Investors may focus more on the forthcoming detailed financials and business updates rather than the scheduling news itself.

Key Figures

Results period: Q4 and full year 2025 Conference date: February 12, 2026 Start time: 8:00 a.m. ET +1 more

Results period

Q4 and full year 2025

Period to be discussed on the Feb 12, 2026 call

Conference date

February 12, 2026

Scheduled date for results conference call and webcast

Start time

8:00 a.m. ET

Start time for the Q4 and full-year 2025 results call

Replay availability

≈2 hours after event

Webcast replay timing on company website

Previous Conferences,earnings Reports

5 past events · Latest: Oct 16

Same Type 5 events

1. Oct 16

   Q3 2025 call notice

   24h Move

   +0.3%

   Scheduled Q3 2025 results call and webcast with replay details.

2. Jul 14

   Q2 2025 call notice

   24h Move

   +0.5%

   Announced Q2 2025 financial results conference call and webcast timing.

3. Apr 17

   Q1 2025 call notice

   24h Move

   +1.9%

   Set date and time for Q1 2025 financial results webcast and call.

4. Feb 06

   FY 2024 call notice

   24h Move

   +0.1%

   Outlined upcoming Q4 and full year 2024 results call and webcast.

5. Oct 17

   Q3 2024 call notice

   24h Move

   +1.0%

   Announced Q3 2024 results and business highlights webcast schedule.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced the company will host a conference call and live webcast on Thursday, February 12, 2026, at 8:00 a.m. ET to report its fourth quarter and full year 2025 financial results and business highlights.

The live webcast will be accessible on the Investors section of the company’s website (www.agios.com) under the “Events & Presentations” tab. A replay of the webcast will be available on the company’s website approximately two hours after the event.

About Agios: Fueled by Connections to Transform Rare Diseases™
At Agios, our vision is to redefine the future of rare disease treatment. Fueled by connections, we build trusted partnerships with communities – collaborating to develop and deliver innovative medicines that have the potential to transform lives. With a foundation in hematology, we combine biological expertise with real-world insights to advance a growing pipeline of rare disease medicines that reflect the priorities of the people we serve. Agios is a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts. To learn more, visit www.agios.com and follow us on LinkedIn and X.

Contacts:
Investor Contact
Morgan Sanford, Vice President, Investor Relations
Agios Pharmaceuticals
morgan.sanford@agios.com

Media Contact
Eamonn Nolan, Senior Director, Corporate Communications
Agios Pharmaceuticals
eamonn.nolan@agios.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Agios (AGIO) report Q4 and full year 2025 results?

Agios will report results on February 12, 2026 with a conference call and webcast at 8:00 a.m. ET.

How can investors access the Agios (AGIO) live webcast on February 12, 2026?

Access the live webcast via the company’s Investors website under the Events & Presentations tab.

Will there be a replay of the Agios (AGIO) February 12, 2026 webcast?

Yes. A replay will be available on the company website approximately two hours after the event.

What topics will Agios (AGIO) cover on the February 12, 2026 call?

The company will report its fourth quarter and full year 2025 financial results and business highlights.

Is registration required to join the Agios (AGIO) webcast on February 12, 2026?

The announcement indicates the webcast is available on the Investors website; follow the Events & Presentations link for access details.